Matches in SemOpenAlex for { <https://semopenalex.org/work/W4312972010> ?p ?o ?g. }
Showing items 1 to 68 of
68
with 100 items per page.
- W4312972010 abstract "Background: We previously showed that S100A1 released from damaged cardiomyocytes can accelerate post-myocardial infarction in vivo healing. The action of S100A1 as a damage-associated molecular pattern seemed to occur via an immunomodulatory (e.g., IL10 increase) and antifibrotic impact (e.g., COL1A1 and ACTA2 downregulation) in cardiac fibroblasts (CFs) via a TRL4/NKFB pathway. The signaling network in CFs conveying this effect has not been characterized yet. Methods and Results: We performed a 48h time-resolved transcriptome analysis on cultured adult rat CF stimulated with rec. human S100A1 protein (10 -6 M). Bioinformatic GSEA yielded an instant and almost exclusive significant upregulation of the chemokine activity GO-term with a delayed suppression of ECM genes. A transcription factor enrichment analysis for the differentially regulated transcripts indicated an immediate activation of NFKB/RELA with a concurrent temporary STAT1 but lasting STAT3 signaling. A secretome LC-MS/MS-based analysis confirmed the shift of S100A1-treated CFs to mostly chemokine secreting cells. With CCL2 as most secreted chemokine and COL1A1 and ACTA2 as established antifibrotic marker genes for released S100A1, we used a RT-PCR readout for these genes in response to siRNA-based knock-down (KD) of STAT1 and STAT3 in S100A1-treated CFs, while TLR4 KD was used to abrogate NFKB/RELA signaling due to known mechanisms (n=10 each group). S100A1 treatment upregulated CCL2 (16-fold*) and downregulated COL1A1 (3.1-fold*) and ACTA2 (2.9-fold*) mRNA expression vs control (*P<0.01) that was blunted by TLR4 KD. STAT3 KD doubled the CCL2 mRNA increase (32.9-fold*), attenuated COL1A1 mRNA downregulation by S100A1 treatment to 2-fold* but left ACTA2 downregulation unaffected vs contr. (*P<0.05). Conversely, STAT1 KD completely blocked the S100A1 mediated downregulation of ACTA2 but neither impacted S100A1-mediated changes in CCL2 nor COL1A1. Conclusion: Our study identifies concurrent STAT1 and STAT3 activation as a modulator of S100A1-mediated TLR4-NFKB signaling in CFs. As S100A1-activated CFs express e.g., IL-10, we speculate that IL-gp130 trans signaling may convey this effect guiding further studies on S100A1’s extracellular effects in the diseased heart." @default.
- W4312972010 created "2023-01-05" @default.
- W4312972010 creator A5040353908 @default.
- W4312972010 creator A5054183084 @default.
- W4312972010 creator A5066057888 @default.
- W4312972010 date "2022-08-05" @default.
- W4312972010 modified "2023-09-29" @default.
- W4312972010 title "Abstract P1071: Concurrent Stat1 And Stat3 Signaling Modulates Tlr4/nfkb-mediated Immunomodulatory And Antifibrotic Effects Of Cardiomyocyte-damaged Released S100a1 Protein In Cardiac Fibroblasts" @default.
- W4312972010 doi "https://doi.org/10.1161/res.131.suppl_1.p1071" @default.
- W4312972010 hasPublicationYear "2022" @default.
- W4312972010 type Work @default.
- W4312972010 citedByCount "0" @default.
- W4312972010 crossrefType "journal-article" @default.
- W4312972010 hasAuthorship W4312972010A5040353908 @default.
- W4312972010 hasAuthorship W4312972010A5054183084 @default.
- W4312972010 hasAuthorship W4312972010A5066057888 @default.
- W4312972010 hasConcept C104317684 @default.
- W4312972010 hasConcept C127561419 @default.
- W4312972010 hasConcept C13373296 @default.
- W4312972010 hasConcept C150194340 @default.
- W4312972010 hasConcept C153911025 @default.
- W4312972010 hasConcept C162317418 @default.
- W4312972010 hasConcept C185592680 @default.
- W4312972010 hasConcept C203014093 @default.
- W4312972010 hasConcept C2776070231 @default.
- W4312972010 hasConcept C2776914184 @default.
- W4312972010 hasConcept C2777003663 @default.
- W4312972010 hasConcept C2778923194 @default.
- W4312972010 hasConcept C502942594 @default.
- W4312972010 hasConcept C55493867 @default.
- W4312972010 hasConcept C62478195 @default.
- W4312972010 hasConcept C86803240 @default.
- W4312972010 hasConcept C95444343 @default.
- W4312972010 hasConceptScore W4312972010C104317684 @default.
- W4312972010 hasConceptScore W4312972010C127561419 @default.
- W4312972010 hasConceptScore W4312972010C13373296 @default.
- W4312972010 hasConceptScore W4312972010C150194340 @default.
- W4312972010 hasConceptScore W4312972010C153911025 @default.
- W4312972010 hasConceptScore W4312972010C162317418 @default.
- W4312972010 hasConceptScore W4312972010C185592680 @default.
- W4312972010 hasConceptScore W4312972010C203014093 @default.
- W4312972010 hasConceptScore W4312972010C2776070231 @default.
- W4312972010 hasConceptScore W4312972010C2776914184 @default.
- W4312972010 hasConceptScore W4312972010C2777003663 @default.
- W4312972010 hasConceptScore W4312972010C2778923194 @default.
- W4312972010 hasConceptScore W4312972010C502942594 @default.
- W4312972010 hasConceptScore W4312972010C55493867 @default.
- W4312972010 hasConceptScore W4312972010C62478195 @default.
- W4312972010 hasConceptScore W4312972010C86803240 @default.
- W4312972010 hasConceptScore W4312972010C95444343 @default.
- W4312972010 hasIssue "Suppl_1" @default.
- W4312972010 hasLocation W43129720101 @default.
- W4312972010 hasOpenAccess W4312972010 @default.
- W4312972010 hasPrimaryLocation W43129720101 @default.
- W4312972010 hasRelatedWork W124126156 @default.
- W4312972010 hasRelatedWork W2028387348 @default.
- W4312972010 hasRelatedWork W2058989785 @default.
- W4312972010 hasRelatedWork W2094538516 @default.
- W4312972010 hasRelatedWork W2127335531 @default.
- W4312972010 hasRelatedWork W2612462661 @default.
- W4312972010 hasRelatedWork W2945829645 @default.
- W4312972010 hasRelatedWork W3047489422 @default.
- W4312972010 hasRelatedWork W4312972010 @default.
- W4312972010 hasRelatedWork W4380883087 @default.
- W4312972010 hasVolume "131" @default.
- W4312972010 isParatext "false" @default.
- W4312972010 isRetracted "false" @default.
- W4312972010 workType "article" @default.